Funding for this research was provided by:
Italian Ministry of Health (GR2011-12; 02350922)
Text and Data Mining valid from 2019-04-27
Received: 6 February 2019
Accepted: 28 March 2019
First Online: 27 April 2019
Ethics approval and consent to participate
: All of the procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1964 and later versions. Written informed consent was obtained from each patient included in the study. The study protocol has been approved by the Ethics Committee of Liguria Region (Italy) (P.R.273REG2016).
: Not applicable.
: Drs. M. Dono and S. Zupo received speaker honoraria from AstraZeneca; Dr. C. Genova discloses being advisory Board member of AstraZeneca and received honoraria from AstraZeneca, Boehringer-Ingelheim, Bristol-Myers-Squibb, Merck Sharp & Dohme and Roche; Dr. F. Grossi received honoraria from AMGEN, AstraZeneca, Bristol-Myers Squibb, Boehringer Ingelheim, Celgene, Merck Sharp & Dohme, Pfizer, Pierre Fabre, Roche.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.